Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應用
3-Trifluoroacetylamino Linagliptin is a derivative of Linagliptin (CAT# L465900), which is a DPP-?4 (dipeptidyl peptidase-?4) inhibitor used in the treatment of type 2 diabetes.
參考文獻
Hameed, S., et al.: J. Clin. Diagn. Res., 15, FC12 (2021); Reijrink, M., et al.: Antioxidants, 10, 1548 (2021); Balasubramanian, V., et al.: Indian J. Chem., Sect. A: Inorg., Bio-inorg., Phys., Theor. Anal. Chem., 60A, 1172 (2021)